Uses of anti-CD40 antibodies

Details for Australian Patent Application No. 2006308860 (hide)

Owner Novartis AG XOMA Technology Ltd.

Inventors Aukerman, Sharon Lea; Luqman, Mohammad

Agent FB Rice

Pub. Number AU-B-2006308860

PCT Pub. Number WO2007/053661

Priority 60/732,580 01.11.05 US

Filing date 1 November 2006

Wipo publication date 10 May 2007

Acceptance publication date 12 January 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/053661 Priority application(s): WO2007/053661

23 October 2008 Alteration of Name

  The name of the applicant has been altered to Novartis AG; XOMA Technology Ltd.

12 January 2012 Application Accepted

  Published as AU-B-2006308860

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006308861-Coupling and release devices and methods for their assembly and use

2006308854-Cell-free synthesis of membrane bound polypeptides